Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-20
2000-07-18
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144, A61K 3140, A61K 3135, A61K 3121
Patent
active
060908300
ABSTRACT:
Lipid lowering dosage units, to be used once a day, produce minimal side effects. They contain a combination of microspheres formulated to co-deliver a HMG-CoA reductase inhibitor component and a niacin component.
REFERENCES:
patent: H1286 (1994-02-01), Eisman et al.
patent: 5157025 (1992-10-01), Aberg et al.
patent: 5260305 (1993-11-01), Dennick
patent: 5445769 (1995-08-01), Rutkowski et al.
patent: 5458823 (1995-10-01), Perkins et al.
patent: 5683720 (1997-11-01), Myers et al.
Myers Michael
Sanghvi Pradeepkumar P.
Fuisz International Ltd.
Jordan Kimberly
Nolan Sandra M.
Schmidt Richard D.
LandOfFree
Controlled release compositions and methods for the treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release compositions and methods for the treatment of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release compositions and methods for the treatment of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037492